Monster Beverage Corp (MNST), The Coca-Cola Company (KO), PepsiCo, Inc. (PEP): Will These Soft Drink Companies Go Flat?
There's no question that America is addicted to caffeine and sugar.
Posts Tagged ‘NYSE:GSK’
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will This Fishy Biotech Go Belly Up?
There are plenty of biotech companies that put all of their eggs in one basket these days.
Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors
Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.
Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week
In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter.
GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...
Mylan Inc. (MYL), GlaxoSmithKline plc (ADR) (GSK), Nationstar Mortgage Holdings Inc (NSM): Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): Does ChemoCentryx Inc (CCXI) Have a Platform Problem?
It hasn't been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI).
GlaxoSmithKline plc (ADR) (GSK), Stryker Corporation (SYK): 3 Alternative Ways to Invest in China’s Booming Health Care Industry
China has loomed large in health care headlines recently, due to the GlaxoSmithKline plc (ADR) (NYSE:GSK) scandal that erupted in July.
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I know it's like comparing apples and oranges, but humor me for a moment.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Netflix, Inc. (NFLX), Advanced Micro Devices, Inc. (AMD), Mylan Inc. (MYL): Today’s Three Best Stocks
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
GlaxoSmithKline plc (ADR) (GSK), China Mobile Ltd. (ADR) (CHL): Will China’s Corporate Crackdown Scare Off Investors?
China's not losing importance in the eyes of investors, despite the world's second-largest economy's slump this year.
Unilever plc (ADR) (UL), GlaxoSmithKline plc (ADR) (GSK), McGraw Hill Financial Inc (MHFI): Emerging Markets, The Show Must Go On!
Emerging-market stocks have been butchered over the past few months amid fears that the Federal Reserve will begin winding down its bond-buying program.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for a treat this week with...
Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment
Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought to market.
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail
Drugs fail their clinical trials for all kinds of reasons. Sometimes, it's related to efficacy; sometimes, it's safety related.
Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it.
Johnson & Johnson (JNJ), AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): The Impact of a Failed Crohn’s Disease Trial Study
A small section of the total Crohn's Disease) patient population is resistant to standard treatment options.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Can This HIV Drug Challenge Gilead Sciences, Inc. (GILD)’s Domination?
ViiV Healthcare -- a joint venture by Pfizer Inc.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?
At the same time, the pharmaceutical industry isn't without its share of risks.
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN), Johnson & Johnson (JNJ): Is This Health Care Stock Underrated?
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one...
ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week
While many investors worried about the Nasdaq's three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn't have come back up.
GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): ChemoCentryx Inc (CCXI) Collapses on Crohn’s Disease Results
Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat.
Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK): The Past, Present, and Future of HIV Treatments
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Someone’s Selling Pfizer Inc. (PFE) Shares, Should You?
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) – CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): China’s Murky Business Climate Won’t Clear Up Soon
A strong week for investors ended especially well in China, as Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week.
Johnson & Johnson (JNJ), Express Scripts Holding Company (ESRX), Gilead Sciences, Inc. (GILD): Three Great Buy-and-Hold Health-Care Stocks
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)'s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc (NASDAQ:SRPT)'s competing Duchenne...
A Smart Eli Lilly & Co. (LLY) Investor Does What Now?
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Sanofi SA (ADR) (SNY), Merck & Co., Inc. (MRK): Healthier Days Loom as 3 Big Pharmas Move on Dengue Shots
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through travel agencies.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
GlaxoSmithKline plc (ADR) (GSK), Roche Holding Ltd. (ADR) (RHHBY): Why Alex Rodriguez Could Bring Big Business to This Sector
Baseball star Alex Rodriguez had an opportunity to be perhaps the greatest player of the past decade or even longer -- that was until he threw it all away by admitting to steroid...
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On
Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.
